Skip Navigation


BJA Advance Access originally published online on August 1, 2006
British Journal of Anaesthesia 2006 97(4):553-558; doi:10.1093/bja/ael209
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
97/4/553    most recent
ael209v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sun, T.
Right arrow Articles by Yao, S.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, T.
Right arrow Articles by Yao, S.-L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Board of Management and Trustees of the British Journal of Anaesthesia 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Alleviation of neuropathic pain by intrathecal injection of antisense oligonucleotides to p65 subunit of NF-{kappa}B

T. Sun1,2, W.-G. Song1,2, Z.-J. Fu2, Z.-H. Liu3, Y.-M. Liu1 and S.-L. Yao1,*

1 Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430022, China
2 Department of Pain Management,Shandong Provincial Hospital Jinan 250021, China
3 Department of Anesthesiology, The Second Hospital in Shenzhen Shenzhen 518035, China

*Corresponding author. E-mail: yaoshanglong{at}eyou.com

Background. Treatment of neuropathic pain remains a challenge. The current study investigated the therapeutic effect of intrathecal administration of NF-{kappa}B antisense oligodeoxynucleotides (ODNs) on mechanical allodynia and thermal hyperalgesia in a chronic constriction injury (CCI) model of rats.

Methods. Lumbar intrathecal catheters were implanted in male Sprague–Dawley rats and a CCI model was established. Thermal and mechanical nociceptive thresholds were assessed with paw withdrawal latency (PWL) to radiant heat and von Frey filaments. The phosphorothioate-modified antisense ODNs to p65 subunit of NF-{kappa}B were administered intrathecally on each of five consecutive days post-CCI. Nuclear NF-{kappa}B p65 expression was assessed by western blot.

Results. CCI induced mechanical allodynia and thermal hyperalgesia and significantly increased NF-{kappa}B p65 protein expression. Intrathecal injection of antisense ODN markedly suppressed the expression of NF-{kappa}B p65 protein and significantly attenuated CCI-induced mechanical allodynia and thermal hyperalgesia.

Conclusion. The activation of NF-{kappa}B pathway may contribute to neuropathic pain in CCI rats. Suppression of NF-{kappa}B could be a potential new strategy for the treatment of neuropathic pain.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 FASEB J.Home page
E. Niederberger and G. Geisslinger
The IKK-NF-{kappa}B pathway: a source for novel molecular drug targets in pain therapy?
FASEB J, October 1, 2008; 22(10): 3432 - 3442.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.